Covid-19 roundup: Moderna vaccine kicks up antibodies against Delta variant; UK study validates mix-and-match approach for Pfizer-AstraZeneca

Jason Mast

Editor

Amber Tong

In an continued effort to monitor the effectiveness of its Covid-19 vaccine, Moderna has rolled out the latest slate of neutralization data against different variants …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Moderna vaccine kicks up antibodies against Delta variant; UK study validates mix-and-match approach for Pfizer-AstraZeneca

Jason Mast

Editor

Amber Tong

Sign up to read this article for free.

Pfizer looking to sell hospital drugs unit — reports

AstraZeneca CEO reaffirms commitment to China following executive's detention

'Expertise is a real thing': FDA commissioner warns of political risk to agency

Merck, AstraZeneca tout Phase 3 win for cancer-turned-rare disease drug

Novartis pays $150M upfront to Schrödinger in new drug deal, ramps up software use

What Will It Take to Reverse Fibrosis in Patients with Advanced MASH?

Covid-19 roundup: Mod­er­na vac­cine kicks up an­ti­bod­ies against Delta vari­ant; UK study val­i­dates mix-and-match ap­proach for Pfiz­er-As­traZeneca

Editor

Sign up to read this article for free.

Covid-19 roundup: Moderna vaccine kicks up antibodies against Delta variant; UK study validates mix-and-match approach for Pfizer-AstraZeneca